MARKET

CNTB

CNTB

Connect Biopharma Holdings Ltd
NASDAQ
2.650
-0.070
-2.57%
After Hours: 2.650 0 0.00% 16:10 02/10 EST
OPEN
2.680
PREV CLOSE
2.720
HIGH
2.680
LOW
2.595
VOLUME
69.12K
TURNOVER
--
52 WEEK HIGH
3.280
52 WEEK LOW
0.5100
MARKET CAP
148.14M
P/E (TTM)
-3.6466
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CNTB last week (0202-0206)?
Weekly Report · 1d ago
Weekly Report: what happened at CNTB last week (0126-0130)?
Weekly Report · 02/02 10:36
Weekly Report: what happened at CNTB last week (0119-0123)?
Weekly Report · 01/26 10:36
Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Context Therapeutics (CNTX) and Connect Biopharma Holdings (CNTB)
TipRanks · 01/21 17:50
Analysts’ Top Healthcare Picks: Context Therapeutics (CNTX), Connect Biopharma Holdings (CNTB)
TipRanks · 01/21 17:00
Weekly Report: what happened at CNTB last week (0112-0116)?
Weekly Report · 01/19 10:43
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance
NASDAQ · 01/15 03:41
BTIG Sticks to Its Buy Rating for Connect Biopharma Holdings (CNTB)
TipRanks · 01/14 11:07
More
About CNTB
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.

Webull offers Connect Biopharma Holdings Ltd (ADR) stock information, including NASDAQ: CNTB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNTB stock methods without spending real money on the virtual paper trading platform.